Trexquant Investment LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$588,435
-72.2%
10,239
-81.9%
0.02%
-74.1%
Q1 2023$2,118,900
+109.0%
56,504
+56.2%
0.06%
+100.0%
Q4 2022$1,013,904
+36.3%
36,185
+36.6%
0.03%
+11.5%
Q3 2022$744,000
-31.8%
26,482
-15.6%
0.03%
-46.9%
Q2 2022$1,091,000
-16.5%
31,363
-13.8%
0.05%
-19.7%
Q1 2022$1,307,000
+329.9%
36,405
+179.1%
0.06%
+221.1%
Q4 2021$304,000
+32.8%
13,042
+4.3%
0.02%
-9.5%
Q1 2021$229,000
-57.5%
12,503
-47.9%
0.02%
-43.2%
Q2 2020$539,000
+36.8%
23,980
+20.8%
0.04%
+8.8%
Q3 2019$394,000
+64.2%
19,853
+68.9%
0.03%
+100.0%
Q1 2019$240,000
+57.9%
11,754
+12.0%
0.02%
-10.5%
Q1 2017$152,000
-22.8%
10,493
-1.6%
0.02%
-38.7%
Q4 2016$197,000
-51.8%
10,669
-68.7%
0.03%
-35.4%
Q1 2016$409,000
-11.1%
34,093
+5.6%
0.05%
+17.1%
Q4 2015$460,000
-43.8%
32,300
-30.7%
0.04%
-55.4%
Q2 2015$819,00046,6140.09%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders